LINC01194 and breast cancer: Forthis we screened B cell culture supernatants against a stringent comparatorusing a positive control monoclonal antibody, Trastuzumab, that recognizes theHER2/neu tumor antigen, expressed on breast cancer cellsand on some melanoma cells [38].